Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.48 EUR | +0.16% | +3.59% | -7.30% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.30% | 8.74B | - | ||
-12.14% | 1.31B | B+ | ||
-1.25% | 1.2B | - | ||
-30.41% | 748M | - | - | |
-.--% | 619M | - | - | |
+6.27% | 475M | - | ||
+2.38% | 433M | - | - | |
-34.41% | 294M | - | - | |
-63.28% | 265M | - | ||
+0.67% | 218M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.